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Abstract
Targeted recombination was carried out to select mouse hepatitis viruses (MHVs) in a defined genetic background, containing an
MHV-JHM spike gene encoding either three heptad repeat 1 (HR1) substitutions (Q1067H, Q1094H, and L1114R) or L1114R alone. The
recombinant virus, which expresses spike with the three substitutions, was nonfusogenic at neutral pH. Its replication was significantly
inhibited by lysosomotropic agents, and it was highly neuroattenuated in vivo. In contrast, the recombinant expressing spike with L1114R
alone mediated cell-to-cell fusion at neutral pH and replicated efficiently despite the presence of lysosomotropic agents; however, it still
caused only subclinical morbidity and no mortality in animals. Thus, both recombinant viruses were highly attenuated and expressed viral
antigen which was restricted to the olfactory bulbs and was markedly absent from other regions of the brains at 5 days postinfection. These
data demonstrate that amino acid substitutions, in particular L1114R, within HR1 of the JHM spike reduced the ability of MHV to spread
in the central nervous system. Furthermore, the requirements for low pH for fusion and viral entry are not prerequisites for the highly
attenuated phenotype.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The spike glycoprotein, found on the virion envelope of
the coronavirus mouse hepatitis virus (MHV), is a major
determinant of viral pathogenicity (Phillips et al., 1999).
Entry into susceptible cells and cell-to-cell spread of MHV
are mediated by the spike. Spike is synthesized as an 180-
to 220-kDa glycosylated precursor that is posttranslationally
cleaved into two 90-kDa subunits, S1 and S2 (Frana et al.,
1985). Oligomeric spike is present on both viral and in-
fected cell membranes. The receptor binding domain (RBD)
of spike has been mapped to the amino-terminal 330 amino
acid residues of the S1 subunit (Kubo et al., 1994), which is
though to form the globular head of the spike. The RBD is
responsible for the initial attachment of MHV to the cell-
surface receptors, members of the CEACAM subclass of the
CEA gene family (Dveksler et al., 1991). This initial bind-
ing event is thought to trigger a conformational change in
spike that allows S2, the stalk portion of the peplomer, to
initiate fusion of the two membranes (Gallagher and Buch-
meier, 2001; Matsuyama and Taguchi, 2002a; Zelus et al.,
2003). A candidate fusion peptide domain has been identi-
fied within S2 (Luo and Weiss, 1998; Fig. 1); however, the
actual fusion peptide for the MHV spike has not been
definitively identified. Within S2 there are two heptad re-
peat (HR) domains (HR1 and HR2) which are structural
features common to all coronavirus spikes as well as of
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attachment/fusion proteins of many other viruses (DeGroot
et al., 1987). More recently, a third heptad repeat region
located to the N-terminal side of HR1 was predicted within
the MHV spike (Gallagher and Buchmeier, 2001; Krueger
et al., 2001). The HR domains are believed to form -helical
configurations, which have been though to play a role in the
oligomerization of the spike peplomer (DeGroot et al.,
1987; Luo et al., 1999). It has also been believed that these
domains participate in the conformational change of the
spike peplomer, which allows for the insertion of the puta-
tive fusion peptide into the cell membrane and that interac-
tions between HR1 and RBD may play a role in fusion
(Krueger et al., 2001; Matsuyama and Taguchi, 2002b).
However, recently, it has been shown that the S1 subunit
contains sequences responsible for oligomerization
(Lewicki and Gallagher, 2003), suggesting that the confor-
mational changes that spike undergoes during the process of
fusion may be quite different from previously postulated.
The entry route for MHV has not been clearly defined.
Previous studies have demonstrated that the wild-type JHM
strain (previously referred to as MHV-4; see Materials and
methods) can utilize both endosomal and nonendosomal
pathways for entry (Nash and Buchmeier, 1997). Wild-type
JHM fuses at neutral pH; however, persistent JHM infection
of a neuronal cell line (OBL21a) gave rise to an acid-
dependent fusion variant OBLV60. OBLV60 is unable to
induce fusion at neutral pH and enters cells via the endo-
somal route (Gallagher et al., 1991; Nash and Buchmeier,
1997). Sequencing of the spike genes of JHM and OBLV60
demonstrated that there were eight amino acid differences
between these two spike proteins. Five of these substitutions
were located in the S1 subunit of the spike gene. However,
it was demonstrated that the change from neutral pH-in-
duced fusion to low pH-induced fusion was dependent on
the amino acid substitutions Q1067H, Q1094H, and
L1114R, all within the first heptad repeat (HR1) of the S2
subunit (Gallagher et al., 1991; see Fig. 1).
JHM is a highly neurovirulent MHV strain (Dalziel et al.,
1986; Gallagher et al., 1991); following infection of sus-
ceptible weanling mice with JHM, there is widespread dis-
tribution of infection in the brain, often resulting in fatal
encephalitis. In contrast, the OBLV60 variant is neuroat-
tenuated; infection with OBLV60 is limited mainly to the
neurons of the mitral and glomerular layers of the olfactory
bulbs, and no fatal encephalitis is observed (Pearce et al.,
1994). We wanted to determine whether the three amino
acid substitutions in the HR1 of the OBLV60 spike were
responsible for its low pH-dependent route of entry into
cells in vitro and/or the attenuation and limited spread of the
virus in vivo. It was also important to determine whether
these phenotypes could be dissociated from each other. We
were particularly interested in the substitution at residue
L1114, as this residue has been substituted in viruses with
altered phenotypes isolated in several studies (Gallagher et
al., 1991; Wang et al., 1992; Saeki et al., 1997).
We have previously used targeted RNA recombination to
demonstrate the important role spike plays as a major de-
terminant of pathogenicity in the central nervous system
(CNS) (Phillips et al., 1999). Subsequently we used recom-
binant viruses expressing chimeric spike proteins to dem-
onstrate that the RBD determines the specificity of receptor
utilization (Tsai et al., 2003). Here we focus on the pheno-
type of a virus encoding the three HR1 amino acids that
were previously shown to be sufficient to result in the low
Fig. 1. Schematic diagram of wild-type and mutant JHM spike proteins. The OBL V60 spike is shown with asterisks marking the positions of the eight amino
acid substitutions within the spike (from amino to carboxyl ends—K107R, N134T, L141F, D597N, Q600K, Q1067H, Q1094H, L1114R) (from Gallagher
et al., 1991). Also shown is the JHM spike, with the locations of the cleavage site represented by the vertical line separating the S1 and S2 subunits, as well
as the heptad repeat (HR) and transmembrane (TM) domains. The HR1 is enlarged to show the locations of the amino acid substitutions in the mutant proteins
containing either three substitutions in HR1 (HR1) or L1114R alone; a candidate fusion peptide (pep1; Luo and Weiss, 1998) within HR1 is also indicated.
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pH-dependent requirement for cell-to-cell fusion (Gallagher
et al., 1991). Thus, we have selected recombinant viruses
with a defined genetic background expressing the JHM
spike protein, encoding the amino acid substitutions in HR1
of OBLV60 (Q1067H, Q1094H, and L1114R) or L1114
alone. The three substitutions are sufficient to confer a
neuroattenuated phenotype to this recombinant virus, which
similar to OBLV60, displays virus spread restricted to the
olfactory bulbs. Interestingly the L1114R substitution alone
is capable of causing in vivo attenuation and restricted
spread, while displaying a fusion phenotype close to wild-
type as well as the ability to enter cells at neutral pH.
Results
Selection and in vitro phenotypes of recombinant viruses
with amino acid substitutions in the HR1 of the spike
protein
We wanted to determine whether the three mutations in
HR1 of the JHM spike, Q1067H, Q1094H, and L1114R,
were sufficient to cause in vivo attenuation and restriction of
antigen to the olfactory bulbs. If so, we then wanted to
determine whether these in vivo phenotypes were dependent
on the in vitro property of acid pH-dependent fusion and
entry (Gallagher et al., 1991; Nash and Buchmeier, 1997).
This was not possible to accomplish with OBLV60, due to
the presence of five other substitutions within S1 (Fig. 1)
and an unknown number of amino acid substitutions outside
of the spike. Thus, we used targeted RNA recombination to
select isogenic recombinant viruses expressing the JHM
spike gene encoding either the three HR1 amino acid sub-
stitutions (SJHM-HR1) or the L1114R alone (SJHM-
L1114R), as well as a virus expressing wild-type JHM spike
(SJHM-RA59) (Kuo et al., 2000; Phillips et al., 2001). (See
Fig. 1 for a schematic of the spike proteins expressed by
these viruses.) All these viruses had genes other than spike
derived from MHV-A59 (Phillips et al., 1999) and are
described under Materials and methods.
SJHM-RA59 replicates to relatively low titers in mouse
L2 fibroblasts in vitro, similar to wild-type JHM (Phillips et
al., 1999, 2001). Compared to JHM or SJHM-RA59 viruses,
OBLV60 and SJHM-HR1 replicated to much higher titers
while SJHM-L1114R replicated to titers intermediate be-
tween those of SJHM-RA59 and SJHM-HR1 (Fig. 2). The
replication characteristics of OBLV60, SJHM-HR1, JHM,
and SJHM-RA59 in OBL21a cells were similar to those in
L2 cells (data not shown).
An in vitro fusion assay was performed to compare the
levels of cell-to-cell fusion induced by recombinant viruses
SJHM-RA59, SJHM-HR1, and SJHM-L1114R. As shown
in Fig. 3, SJHM-HR1 lacks the ability to induce cell-to-cell
fusion at neutral pH. This is consistent with previous data on
the inability of OBLV60 to induce cell-to-cell fusion at
neutral pH (Gallagher et al., 1991) and confirms the obser-
vation that the three amino acid substitutions in HR1
(Q1067H, Q1094H, and L1114R) present in both SJHM-
HR1 and OBLV60 are sufficient to confer a fusion-negative
phenotype at neutral pH. SJHM-L1114R, expressing the
L1114R substitution alone, does induce significant levels of
cell-to-cell fusion at neutral pH; however, fusion induced by
this recombinant is less extensive than that induced by
SJHM-RA59 (Fig. 3). Thus, the L1114R substitution is not
sufficient to confer the nonfusogenic phenotype of SJHM-
HR1.
Fig. 2. Replication of wild-type and mutant viruses in L2 cell culture. L2
cells were infected in duplicate at an m.o.i. of 2 PFU/cell. At the indicated
times postinfection, cells were lysed and virus titered by plaque assay.
Each point represents the logarithmic mean titer of duplicate samples. (A)
Cells were infected wild-type JHM virus (wtJHM), OBLV60, or recom-
binant viruses SJHM-RA59, expressing wild-type JHM spike (JHM) or
SJHM-HR1, expressing the JHM spike with three HR1 substitutions
(HR1). (B) Cells were infected with the following recombinant viruses:
SJHM-RA59 (JHM); SJHM-HR1 (HR1); or two independent isolates of
SJHM-L1114R, expressing JHM spike with the L1114R substitution
(L1114R-A; L1114R-B).
Fig. 3. Virus-induced cell-to-cell fusion of L2 cells. L2 cell monolayers
were infected in duplicate at an m.o.i. of 1 PFU/cell with recombinant
viruses expressing either wild-type or mutant spike proteins. At 7 and 9 h
postinfection, the cells were fixed and visualized at 200 magnification
using phase-contrast microscopy. Fusion expressed as the mean percentage
of nuclei in syncytium is plotted with the error bar representing the
standard deviation.
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To determine whether, similar to OBLV60, the mutant
recombinant viruses rely on the acidification of the endoso-
mal vesicles to trigger fusion, we tested the effects of the
lysosomotropic agent, ammonium chloride, on the replica-
tion of SJHM-RA59, SJHM-HR1, and SJHM-L1114R in
vitro (Fig. 4). Vesicular stomatitis virus (VSV), which is
known to enter cells via the endosomal pathway and to
require low pH for entry, was used as a control. In the
presence of 20 mM ammonium chloride, the replication of
VSV was reduced about 10,000-fold at 12 and 24 h postin-
fection of L2 cells (Fig. 4). Similarly, the replication of
SJHM-HR1 was reduced more than 1000-fold in the pres-
ence of 20 mM ammonium chloride. Similar levels of in-
hibition were observed for OBLV60 (Gallagher et al., 1991;
our data, not shown). In contrast, only a minimal reduction
in replication level was observed when either SJHM-RA59
or SJHM-L1114R infection of L2 cells was carried in the
presence of ammonium chloride. (Statistical analysis dem-
onstrated, however, that SJHM-L1114R was inhibited to a
greater extent than SJHM-RA59.) Similar patterns of inhi-
bition were observed in infections carried out in the pres-
ence of 40 M chloroquine (data not shown). Thus, the
L1114R substitution alone does not result in an absolute
dependence on low pH for virus entry.
Recombinant viruses with HR1 mutations are
neuroattenuated and restricted in spread in the brain
despite efficient replication
Wild-type JHM or recombinant viruses encoding the
JHM spike (SJHM-RA59) are highly neurovirulent and dis-
seminate throughout the murine brain, often causing mor-
tality (Lavi et al., 1990; Barnett et al., 1993; Phillips et al.,
1999). OBLV60 is a highly neuroattenuated mutant of JHM
(Pearce et al., 1994). To determine whether the three amino
acid substitutions in the HR1 of OBLV60 or L1114R alone
are sufficient to confer a neuroattenuated phenotype, mice
were inoculated either intracranially (ic) or intranasally (in)
with serial dilutions of SJHM-RA59, SJHM-HR1, and
SJHM-L1114R and observed for disease and death. Inocu-
lation with SJHM-HR1 (up to 5000 PFU ic and up to 105
PFU in) or with SJHM-L1114R (up to 104 PFU ic) did not
result in any mortality throughout the 21 to 28 days the mice
were observed. In contrast, mice inoculated with doses as
low as 1 PFU ic or 1000 PFU in of SJHM-RA59 exhibited
clinical signs of disease, such as hunched posture, ruffled
fur, and abnormal gait with occasional paralysis, at 4–5
days postinfection. Thus, recombinant viruses expressing
either all three HR1 substitutions or L1114R alone induced
clinically silent infections and are basically avirulent. Even
L1114R alone is sufficient to highly attenuate MHV.
To begin to understand the mechanism of the attenuation
of SJHM-HR1 and SJHM-L1114R, we examined the ability
of these viruses to replicate and express viral antigen in the
brain. We used the in route of inoculation because it is a
more natural route and detection of viral antigen following
in inoculation is more discreet than following ic inoculation.
Thus, mice were inoculated in with 5000 PFU each of
SJHM-RA59, SJHM-HR1, or SJHM-L1114R and titers of
infectious virus in the brain at various times postinfection
were determined by plaque titration. Patterns of infection
with all of these viruses were similar in terms of kinetics
and extent of replication; viral replication in the brain
peaked at 5 days postinfection (Fig. 5). SJHM-HR1 dis-
played slightly higher viral titers at 5 and 7 days postinfec-
tion as compared to SJHM-RA59; however, the difference
Fig. 4. Effect of lysosomotropic agents on viral replication in L2 cells. L2
cell monolayers were treated for 1 h with 20 mM ammonium chloride and
then infected with either vesicular stomatitis virus (VSV) or recombinant
MHVs expressing wild-type or mutant spikes as indicated. The presence of
20 mM ammonium chloride was continuous throughout the infection. At 0,
12, and 24 h postinfection, the level of infectious titer was measured by
plaque assay and expressed as the difference between logarithmic mean (
log10(PFU/ml)) titer of the treated and untreated samples (four independent
samples per virus). The error bars represent the standard deviations.
Fig. 5. Replication of virus in brains of infected mice. Four-week-old
C57B1/6 mice were inoculated intranasally with 5000 PFU of recombinant
viruses expressing wild-type or mutant JHM spikes as indicated. At the
indicated times, mice (three per time point) were sacrificed and brains
harvested and homogenized. Viral titers were determined by plaque assay
of brain homogenates and expressed as the logarithmic mean titer per gram
of tissue homogenate. The standard deviations of the mean are plotted as
error bars. The limit of detection of this assay was 2.7 log10(PFU/g).
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was less than 1.0 log10 unit. SJHM-L1114R replicated less
efficiently than SJHM-RA59; however, the difference be-
tween the titer of infectious virus in the brains of mice
infected with these two viruses at 5 days postinfection was
not significant (two-tailed t test, P  0.06 and P  0.11 for
each of the two SJHM-L1114R isolates). Thus, although
there is a striking difference in virulence after in inoculation
with these viruses, this difference cannot be explained by
the extent of viral replication in the brains of infected
animals.
To further investigate the attenuated phenotype of these
mutants, we used indirect immunofluorescence to visualize
viral antigen in the brains of SJHM-HR1- and SJHM-
L1114R-infected animals. Brain sections were obtained
from mice infected in with 5000 PFU of SJHM-RA59,
SJHM-HR1, and SJHM-L1114R at 5 days postinfection.
These sections were labeled with polyclonal antisera di-
rected against MHV structural proteins and then detected
using a biotin-avidin-labeled secondary antibody as de-
scribed under Materials and methods. The difference in the
patterns of viral antigen distribution observed in the brains
of animals infected with SJHM-RA59 and the viruses ex-
pressing mutant spike was striking. The distribution of
SJHM-RA59 viral antigen was widespread. Viral antigen
was detected in olfactory bulbs, as well as in other regions
of the brain, from the basal forebrain to the brain stem
(Phillips et al., 1999). (Fig. 6 shows sections from the basal
forebrain and the olfactory bulbs.) However, in mice in-
fected with SJHM-HR1 or SJHM-L1114R, viral antigen
was primarily detected in the mitral layer of the olfactory
bulbs and in the adjacent glomerular and external plexiform
layers (see below). Outside the olfactory bulbs, there were
only occasional antigen-positive cells. The majority of an-
tigen-positive cells looked morphologically similar to neu-
rons. Thus, both mutants showed patterns of antigen distri-
bution similar to OBLV60 (Pearce et al., 1994); this
Fig. 6. Viral antigen distribution in the brains of infected mice. Indirect immunofluorescent staining of viral antigen with rabbit anti-MHV-A59 serum was
carried out on paraffin-embedded sagittal sections from brains collected on day 5 postinfection from mice infected with SJHM-RA59, expressing wild-type
JHM spike (a, b); SJHM-HR1, expressing JHM spike with three HR1 substitutions (c, d); or SJHM-L1114R, expressing the JHM spike with the L1114R
substitution alone (e, f). Shown are regions of the olfactory bulbs (a, c, e) and the basal forebrain (d, f, g). The secondary antibody was TRITC-conjugated
swine anti-rabbit antibody. Bars, 20 m.
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indicates that the L1114R substitution alone, as well as the
three HR1 substitutions, is sufficient to restrict antigen ex-
pression to the olfactory bulbs.
We quantified the spread of SJHM-RA59, SJHM-HR1,
and SJHM-L1114R antigen in the brain at day 5 postinfec-
tion by staining with immunofluorescent antibody and
counting the number of antigen-positive cells in regions of
the brain, including the olfactory bulbs and regions caudal
to it (Fig. 7). From these data, it is clear that, while mice
infected with all three viruses displayed viral antigen in the
olfactory bulbs, only mice infected with SJHM-RA59 had
significant numbers of infected cells in the other regions of
the brain. By 7 days postinfection, the intense staining of
SJHM-RA59 antigen in the olfactory bulbs had diminished
and shifted to the pons and medullar regions (data not
shown). Some SJHM-HR1 and SJHM-L1114R antigen
staining was also observed in the more caudal regions of the
brain, but it was of lower intensity and less extensive than
SJHM-RA59 antigen.
There were some differences among the viruses in anti-
gen spread within the olfactory bulbs as well. SJHM-RA59
antigen was found mostly in the mitral layer, often in cells
with neuronal morphology; the glomerular layer of the ol-
factory bulbs was also labeled but less intensely than the
mitral layer (data not shown). In addition, some SJHM-
RA59 antigen was detected in deeper cell layers. The mu-
tant virus antigen was found in abundance in the glomerular
layer as well as in the mitral layer of the olfactory bulbs, and
occasionally in the intervening external plexiform layer.
There was less antigen present in deeper layers of the
olfactory bulbs as compared with SJHM-RA59 antigen.
To further understand how the viruses expressing mutant
spike proteins can replicate to similar titers as virus express-
ing wild-type JHM spike (SJHM-RA59), yet express mini-
Fig. 7. Quantification of viral antigen expression in the brain. Indirect immunofluorescent staining of viral antigen was carried out on paraffin-embedded
sagittal brain sections as described in Fig. 6 and under Materials and methods. The number of antigen-positive cells in each of the indicated regions of the
brain at 5 days postinfection was counted under 100 magnification. Three animals were examined per virus. For each mouse, the numbers from duplicate
sections were averaged and plotted; thus the numbers shown are averages of six sections. (A) SJHM-RA59, expressing wild-type JHM spike; (B) SJHM-HR1
expressing the JHM spike with three HR1 substitutions; (C and D) two isolates of SJHM-L1114R, expressing the JHM spike with the L1114R substitution.
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mal if any antigen outside of the olfactory bulbs, we quan-
tified the amount of infectious virus in olfactory bulbs as
compared with the rest of the brain (Fig. 8). In mice infected
with either the single or the triple substitution HR mutants,
the level of infectious virus within the olfactory bulbs was
2–5 log10 units greater than that in the rest of the brain. (The
distribution of infectious virus was similar in brains from
mice infected with OBLV60 (Fig. 8; Pearce et al., 1994).)
For recombinant virus expressing wild-type JHM spike,
approximately equal amounts of infectious virus were de-
tected in the olfactory bulbs and the rest of the brain. Thus,
for each virus, the amount of infectious virus present in the
olfactory bulb as compared with the rest of the brain is
consistent with level of viral antigen detected in each frac-
tion (Fig. 6–8). For all viruses examined, the olfactory
bulbs are an abundant source of infectious virus. The olfac-
tory bulbs represent approximately 6% of the weight of the
brain, yet even in animals infected with recombinant ex-
pressing wild-type spike, olfactory bulbs contain close to
half the infectious virus.
Examination of inflammation in the CNS of mice in-
fected with all three viruses, by staining of brain sections
with hematoxylin and eosin, revealed pathologic changes
consistent with acute meningoencephalitis. The relative in-
tensity of inflammation varied from a few foci of perivas-
cular cuffing to widespread foci with extensive parenchymal
infiltration of lymphocytes and activated microglial cells
with tissue necrosis. The observed levels of CNS inflam-
mation were consistent with the levels of viral antigen-
positive cells. By 5 days postinfection, inflammation was
extensive for SJHM-RA59 in the olfactory bulbs and the
rest of the brain; however, in SJHM-HR1- and SJHM-
L1114R-infected brains, severe inflammation was found
almost exclusively in the olfactory bulbs. By 7 days postin-
fection, inflammation was observed in more caudal regions
of the brain for SJHM-HR1 and SJHM-L1114R; however,
the extent and the intensity of inflammation were markedly
less than that observed in the brains of mice infected with
SJHM-RA59.
Discussion
Our goals were to determine (1) whether the three HR1
amino acid substitutions observed in the OBLV60 spike
protein were indeed responsible for the low pH-dependent
step in viral entry and/or the attenuated phenotype in vivo
and (2) whether the attenuation and olfactory bulb localiza-
tion observed for OBLV60 were linked to the fusion phe-
notype. Thus, we used targeted recombination to select
viruses in a defined genetic background, differing from the
parental virus only in the three mutations in HR1 of S2.
These viruses express the JHM spike protein containing the
three HR1 substitutions present in the OBLV60 spike
(Q1067H, Q1094H, and L1114R). The genes other than the
spike in these viruses were derived from MHV-A59. We
had shown previously that the parental virus used for com-
parison for these experiments, SJHM- RA59, which con-
tains the wild-type JHM spike, displays in vitro properties
and the high neurovirulence phenotype exhibited by wild-
type JHM (Phillips et al., 1999). We found that the recom-
binant virus, expressing the JHM spike with HR1 mutations.
SJHM-HR1, displays similar phenotypes to OBLV60 (Gal-
lagher et al., 1991; J.C. Tsai and S.R. Weiss, unpublished
data). As described above, this includes sensitivity to lyso-
somotropic agents, inability to induce cell-to-cell fusion at
neutral pH, as well as in vivo attenuation. Thus, with respect
to the HR1 substitutions within JHM spike, the background
Fig. 8. Quantification of infectious virus in the olfactory bulbs and the brain parenchyma. Male 4-week-old C57B1/6 mice were inoculated intranasally with
5000 PFU of recombinant virus expressing wild-type JHM spike (JHM), with mutant spike proteins, either with three HR1 substitutions (HR1) or L1114R
alone (L1114R) or with OBLV60. Mice were sacrificed 5 days postinfection and brains were harvested. Olfactory bulbs (OB) were separated from the rest
of the brain parenchyma (BP). Both fractions were homogenized and infectious virus was quantified in each fraction by plaque assay. Also shown are the
total brain titers, which are the sums of both fractions. Titers are expressed as the logarithmic mean of total PFU and standard deviations are represented as
error bars. The limit of detection was 2.7 log10 (PFU) for the BP.
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genes of the virus (MHV-A59 or JHM) do not influence the
phenotypes that we have studied here.
Previous studies reported that the OBLV60 spike protein
can induce cell-to-cell fusion if exposed to low pH for
several hours (Gallagher et al., 1991). In our studies, neither
SJHM-HR1 nor OBLV60 was able to induce cell-to-cell
fusion, at neutral or low pH, even after incubation of in-
fected cells at low pH for several hours. The difference
between our observations and those of Gallagher et al.
(1991) may be due to the way spike was expressed; Gal-
lagher et al. (1991) utilized a vaccinia virus expression
system, perhaps resulting in higher levels of cell-surface
spike expression than those present during natural infection.
The acidic pH requirement for OBLV60 entry was dem-
onstrated using a variety of lysosomotropic agents at vari-
ous times during infection (Gallagher et al., 1991; Nash and
Buchmeier, 1997). Similar to OBLV60, the recombinant
virus expressing a spike with the three HR1 substitutions
was nonfusogenic at neutral pH and its replication was
sensitive to inhibition by lysosomotropic agents; this dem-
onstrates that the HR1 substitutions identified in the
OBLV60 spike are indeed responsible for the low pH re-
quirement in viral entry. Our observations that SJHM-HR1
is highly attenuated in neurovirulence and restricted in
spread from the olfactory bulbs into the more caudal areas
of the brain allow us to conclude that the HR1 substitutions
are responsible for the altered pathogenesis displayed by
OBLV60 (Pearce et al., 1994).
To determine whether the L1114R substitution alone was
responsible for any of the phenotypes of the SJHM-HR1, we
selected recombinants with a spike containing only this
substitution, SJHM-L1114R. We reasoned that this substi-
tution could be responsible for only some of the phenotypes
and thus that comparison of SJHM-L1114R with SJHM-
HR1 would indicate whether the in vitro changes observed
were responsible for and/or linked to the in vivo pheno-
types. SJHM-L1114R induced syncytia at neutral pH, albeit
at a lower level than SJHM- RA59; furthermore SJHM-
L1114R was relatively resistant to the effects of lysosomo-
tropic agents, but not quite as resistant as parental SJHM-
RA59. Yet, the SJHM-L1114R viruses were attenuated and
displayed antigen only in the olfactory bulbs. This demon-
strates that the L1114R substitution is sufficient to cause
altered pathogenesis and suggests that the low pH-depen-
dent phenotype displayed by OBLV60 and SJHM-HR1 is
not required for neuroattenuation and restricted spread
within the CNS.
The HR domains of the MHV spike have been impli-
cated in the mechanism of cell-to-cell fusion (Gallagher and
Buchmeier, 2001; Krueger et al., 2001; Matsuyama and
Taguchi, 2002b). By analogy with other viral spike proteins,
such as HIV gp41 and influenza HA2, it is believed that
conformational changes in spike, mediated by intramolecu-
lar heptad repeat interactions, are necessary to promote
fusion through the insertion of the hydrophobic fusion pep-
tide in the opposing cell’s membrane (White, 1992; Carr et
al., 1997; Singh et al., 1999). The three substitutions present
in the SJHM-HR1 spike are found within HR1, downstream
of the putative fusion peptide (Luo and Weiss, 1998). We
have observed previously that uncharged-to-charged amino
acid changes within HR1, such as L to R, can affect the
ability of the MHV spike to induce cell-to-cell fusion de-
spite the fact that such spike molecules are processed and
delivered to the plasma membrane (Luo and Weiss, 1998).
Gallagher et al. (1991) suggested that the acquisition of a
titratable proton and/or positive charge, as a result of the
Q-to-H substitutions within the OBLV60 spike HR1, could
result in the requirement for a low pH (pH 6) environment
for the activation of fusion. However for the OBLV60 spike
and the spike proteins studied here, multiple substitutions
were necessary for the low pH requirement for fusion; in a
vaccinia virus based expression system, neither spike pro-
teins with the L1114R alone nor proteins with both Q-to-H
substitutions without L1114R could induce the altered fu-
sion phenotype (Gallagher et al., 1991). Consistent with
this, the L1114R substitution alone results in only a small
decrease in the ability to induce cell-to-cell fusion at neutral
pH and does not confer significant sensitivity to ammonium
chloride (Figs. 3 and 4).
Substitutions at L1114 within the JHM spike (L1114R or
L1114F) are particularly intriguing in that they have been
reported in association with several mutant phenotypes. In
addition to L1114R in the OBLV60 spike (Gallagher et al.,
1991), substitutions at this residue have been identified in
the spike of a monoclonal antibody resistant mutant (Wang
et al., 1992) and a soluble receptor resistant mutant, srr7
(Saeki et al., 1997). The srr7 mutant (expressing a spike
containing L1114F) demonstrated increased stability of the
S1/S2 interaction, the loss of the ability to induce
CEACAM-independent fusion (Taguchi and Matsuyama,
2002), and altered interactions with CEACAM1b as well as
soluble receptor (Matsuyama and Taguchi, 2002a, b). Sim-
ilarly, OBLV60 exhibits increased thermostability (M.
Buchmeier, personal communication) and loss of the ability
to induce CEACAM-independent fusion (T. Gallagher, per-
sonal communication). The recombinant virus expressing
L1114R alone (described in this article) is also unable to
induce CEACAM-independent cell-to-cell fusion (data not
shown). Finally, recombinant viruses expressing A59/JHM
chimeric spikes were also neuroattenuated, thermostable,
and unable to induce receptor independent cell-to-cell fu-
sion (Tsai and Weiss, 2001; Tsai et al., 2003). Thus, these
data are consistent with the observation that high thermo-
lability, the ability to induce receptor-independent fusion,
and the propensity to dissociate from receptor are associated
with high neurovirulence and rapid spread in the CNS and
relatively less efficient replication in cultured cells, dis-
played by JHM (Krueger et al., 2001; Gallagher and Buch-
meier, 2001; Phillips et al., 1999).
Interestingly, the restriction of antigen expression to the
olfactory bulbs did not result in a difference in brain titers
between mutant and wild-type recombinant viruses. By day
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5, both SJHM-RA59 and mutant viruses (SJHM-HR1 and
SJHM-L1114R) replicated to much higher titers, per gram
of tissue in the olfactory bulb, as compared with the rest of
the brain (Fig. 8). Thus, the titer of infectious virus in the
olfactory bulbs represents a large fraction of total virus in
the brain and the ability of virus to replicate in the olfactory
bulb is sufficient to achieve a high titer. Furthermore, the
observation that the recombinant viruses expressing mutant
spikes replicated to similar titers as wild-type is consistent
with previous observations that the level of replication of
MHV in the CNS is not necessarily reflective of the neuro-
virulence level (Phillips et al., 1999).
It is plausible that the L1114R (or F) substitution alters
the structure of the spike protein such that the mutant spike
protein is less fit than wild-type and thus viral spread is
impaired or slowed down compared to virus expressing
wild-type JHM spike. Alternatively, it is possible that the
neurons of the olfactory bulbs are different from other
neurons (perhaps, for example, in receptor expression) and
that viruses with the L1114R substitution cannot replicate in
cells outside the olfactory bulbs. However, this is not an
absolute restriction, because at later times postinfection,
increased numbers of infected cells are detected outside of
olfactory bulbs (data not shown). Consistent with this ob-
servation, OBLV60 can spread beyond the olfactory bulbs
when the immune response is compromised (Pearce et al.,
1994). Thus, it is likely that the differences in the efficiency
of replication between the mutant and the wild-type recom-
binant viruses in the CNS give the immune response an
advantage that restricts spread sooner and more efficiently
than for wild-type virus.
Materials and methods
Cells and viruses
Murine L2, 17C1-1 and DBT cells, and feline FCWF
cells were maintained in tissue culture flasks in Dulbecco’s
minimal essential medium (DMEM) supplemented with
10% fetal bovine serum (FBS) (Gibco-BRL). JHM and
OBLV60 were obtained from Dr. M. Buchmeier (La Jolla,
CA). (The JHM isolate we are using has previously been
referred to in the literature as MHV-4 (Dalziel et al., 1986;
Gallagher et al., 1991). The coronavirus nomenclature com-
mittee has decided to eliminate the use of the MHV-4
nomenclature; thus, all isolates of JHM are referred to
simply as JHM.) We have used two independently selected
recombinant viruses containing the JHM spike gene with
the rest of the genes derived from MHV-A59. These were
called S4R22 and S4R29 in previous publications (Navas et
al., 2001; Phillips et al., 2001, 2002). These two isolates
behave identically and will be referred to collectively as
SJHM-RA59, that is, a recombinant A59 with the spike
gene derived from JHM, SJHM-RA59 serves as the recom-
binant wild-type virus. fMHV (obtained from Paul Masters,
Albany, NY) is a recombinant virus, which expresses the
ectodomain of the feline infectious peritonitis (FIPV) S
gene in the MHV-A59 background (Kuo et al., 2000; On-
tiveros et al., 2001).
Plasmids and PCR mutagenesis
pSwt, encoding the wild-type JHM (MHV-4) spike in
pGEM4Z, was obtained from Dr. Michael Buchmeier (Gal-
lagher et al., 1991); pSwt was further modified to construct
pGEM4Z-S4. AvrII and Sbf1 restriction sites were created at
the 5 and 3 ends of the spike gene, as described previously
(Phillips et al., 1999). pMH54-S4 was subsequently con-
structed by the ligation of the JHM spike gene (excised from
pGEM4Z-S4 by digestion with AvrII/SbfI) into AvrII/SbfI-
cleaved pMH54, in place of the MHV-A59 spike gene
(Phillips et al., 1999). The plasmid pS-OBL60 (obtained
from Michael J. Buchmeier) is a pGEM4Z plasmid, which
contains the spike gene of the OBLV60 virus (Fig. 1).
The spike gene of OBLV60 was amplified from pS-
OBLV60 by PCR using the primers JJ3 and A59-9 (Table 1;
Phillips et al., 1999). The amplified OBLV60-fragment was
digested with BamHI and PstI and a 1166 base pair frag-
ment, encoding the three mutations in HR1 (Q1067H,
Q1094H, and L1114R), was subcloned into the correspond-
ing site in pGEM4Z-S4. The resulting plasmid was called
pGEM-OBLV60(HRImut). The AvrII/SbfI fragment from
this plasmid, containing the mutant spike gene, was sub-
cloned into pMH54-S4 to yield pMH-OBLV60(HR1mut).
The spike gene encoded in pMH-OBLV60(HR1mut) was
sequenced to verify that the three target mutations, and no
additional mutations, were introduced. PCR- mediated mu-
tagenesis to introduce the L1114R substitution was carried
out in pG-MHV4S, a derivative of pGEM4Z-S4 that con-
tains the full start signal upstream of the AvrII site. The
mutagenic primer JFSL1114R2, which encodes the L1114R
substitution (generated by a C-to-T at nucleotide 3340 and
a T-to-C at nucleotide 3342 of the spike gene), and JRS-
SBF (Table 1) were used to amplify the 3 end of the S gene.
This fragment was digested with HincII and SbfI and sub-
cloned into pG-MHV4S to generate pG-L1114R. After ver-
ifying the sequences in the amplified region, the AvrII/SbfI
fragment of the spike gene was ligated into pMH54, gen-
erating pMH-L1114R.
Targeted RNA recombination
Targeted RNA recombination was used to generate the
recombinant viruses (Kuo et al., 2000; Phillips et al., 2001).
The recombinant viruses express the JHM spike with the
rest of the background genes derived from A59. Synthetic
capped RNAs were synthesized by linearizing the plasmids
pMH54-S4, pMH-OBLV60(HR1mut), and pMH-SJHM-
L1114R using the restriction enzyme PacI and then tran-
scribing with T7 polymerase (Ambion). Recombination was
carried out between the donor RNA and the recipient virus,
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fMHV in feline FCWF cells (Kuo et al., 2000; Phillips et al.,
2001), and the recombinants selected by their ability to
replicate in murine L2 cells; individual isolates were puri-
fied by two rounds of plaque purification on L2 cells. Two
independently selected recombinant viruses for each mutant
were chosen for further study. The pair expressing all three
mutations in HR1 were called SJHM-HR1-R120 and
SJHM-HR1-R121 and are referred to collectively as SJHM-
HR1. The pair expressing L1114R only were called SJHM-
L1114R-R300 and SJHM-L1114R-R301 and are referred to
collectively as SJHM-L1114R or when data is shown for
each isolate as SJHM-L1114R-A and SJHM-L1114R-B,
respectively. (We have shown in the past that pairs of
independently selected recombinant viruses with the same
mutations exhibit identical phenotypes (Leparc-Goffart et
al., 1998; Phillips et al., 1999, 2001).)
All recombinant MHV spike genes were sequenced in
full, using previously described primers (Leparc-Goffart et
al., 1997; Phillips et al., 1999) and compared to the pub-
lished JHM spike gene sequence (Parker et al., 1989). Our
wild-type JHM spike gene has in addition one silent muta-
tion at nucleotide 3990 (Gallagher et al., 1991) and an
L255A substitution (Phillips et al., 1999). The spike of
SJHM-HR1-R120 contained no additional amino acid sub-
stitutions; however, the spike of SJHM-HR1-R121 did have
another amino acid substitution, N78D. Thus we show data
for SJHM-R120 for all of the experiments. Spike protein
expressed by SJHM- L1114R-R300 and SJHM-L1114R-
R301 had no additional substitutions.
Virus replication in vitro
One-step replication curves were carried out in L2 cell
monolayers and virus was titered by plaque assay on L2
cells, as previously described (Phillips et al., 2001). To
investigate the inhibitory effects of lysosomotropic agents
on virus replication, L2 cells were pretreated with medium
containing either 20 mM ammonium chloride (Sigma) or 40
mM chloroquine (Sigma) for 1 h prior to infection. Cells
were infected at an m.o.i. of 1 PFU/ cell at 37°C for 1 h, and
the inoculum was removed. The cells washed with phos-
phate-buffered saline (PBS) and medium containing the
same concentrations of chloroquine or ammonium chloride
was added back. At the indicated times postinfection, cells
were lysed and viral titers were determined by plaque assay
(Phillips et al., 2001). (Only the data for ammonium chlo-
ride treatment are shown.)
Cell-to-cell fusion assay
L2 monolayers were infected at a multiplicity of infec-
tion of 1 PFU per cell and incubated in DMEM-10% FBS at
37°C. At 7 or 9 h postinfection, the monolayers were
washed with PBS and fixed with 2% paraformaldehyde
(Sigma Chemical Co., St. Louis, MO). Syncytium forma-
tion was quantified by counting the number of nuclei in
syncytium and the number of single nuclei per field at200
magnification. A total of 10 fields, of approximately 200
nuclei each and from duplicate wells, were counted per
virus. The average and the standard deviation of the per-
centage of cells that were fused were calculated. The per-
centage of fusion was calculated by the following formula:
% fusion  nuclei in syncytium/total number of nuclei per
field.
Infections in mice
Virus-free, male 4-week-old C57BL/6 mice from NCI
were used for all animal experiments. Viruses were diluted
into PBS containing 0.75% bovine serum albumin. Mice
were anesthetized with isofluorane (IsoFlo, Abbott Labora-
tories, North Chicago, IL). For intracranial inoculations, 20
l of diluted virus was injected into the left cerebral hemi-
sphere. For intranasal inoculation, 5 l of the diluted virus
was introduced into each nostril. For mock-infected con-
trols, an uninfected cell lysate at a comparable dilution was
used for inoculation. Virulence was measured in lethal dose
(LD)50 units, the amount of virus needed to kill 50% of the
mice. Mice were inoculated ic or in with serial dilutions of
virus, five mice per dilution, and were examined for signs of
disease or death on a daily basis up to 28 days postinfection.
LD50 values were calculated by the Reed–Muench method
(Reed and Muench, 1938; Lavi et al., 1984).
To measure the kinetics of virus replication, mice were
infected in. Groups of mice (three to four mice) were sac-
rificed at 1, 3, 5, and 7 days postinfection and perfused with
Table 1
Primers used for PCR mutagenesis
Primer Sequence (5 to 3) Polarity Genome location
A59-9 TCTGATGTTGGCTTTGTCGAGG Positive 2503–2824 of spike gene
JJ3 gcggatccaagtCCtGcAGgGGCTGTGATAGTCAATCCTCATGAGA Negative Intergenic region between S
and 4a
JFSL1114R2 GCAGGTTAACTGCACTTAATGCGTATATATCCAAGCAATTCAGTGATAGTA Positive 3302–3352 of spike gene
JRS-SBF CGTAAGTCCTGCAGGGGCTGTGATA Negative Intergenic region between S
and 4a
a Nonviral sequences, used to introduce restriction sites or new codons, are indicated by lower case.
b The locations are designated by nucleotide positions in the spike (S) open reading frame (ORF).
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10 ml of PBS, prior to removal of the brain. The left half of
the brain (cut sagittally) was placed directly into 2 ml of
isotonic saline with 0.16% gelatin for virus titer determina-
tion. The right half of the brain was stored in 8–10 ml of
10% phosphate-buffered formalin for histology and viral
antigen staining (see below). All organs were weighed and
stored at 80°C until titers were determined. Organs were
homogenized and virus titers were measured by plaque
assay on L2 cell monolayers. For the quantification of virus
in the olfactory bulbs and the rest of the brain (Fig. 8),
olfactory bulbs were separated from the rest of the brain
parenchyma and each fraction was placed into gel saline,
homogenized, and titered for infectious virus by plaque
assay on monolayers of L2 cells.
Histology and immunofluorescence
The formalin fixed tissue (right half of the brain, see
above) was embedded in paraffin, sectioned, and stained
with hematoxylin and eosin (H&E) for histological analysis,
or left unstained for analysis of viral antigen distribution by
indirect immunofluorescence. Following removal of the
paraffin, slides were transferred to a 0.01 M citric acid bath
at 96°C for 15 min, allowed to cool to room temperature,
and then washed in double-deionized water. Sections were
blocked with 1.5% goat serum in 0.1 M Tris–HCl and 1%
Triton X-100 for up to 1 h, incubated for 2 h with UV13, a
polyclonal antiserum raised against MHV-A59 (obtained
from Mark Denison, Vanderbilt University). The subse-
quent incubation with the secondary antibody, biotin-con-
jugated goat anti-rabbit immunoglobulin (Vector Labs, CA)
for 1 h, was followed by incubation with tetramethylrho-
damine-5 (and 6) isothiocyanate (TRITC)-conjugated goat
anti-rabbit immunoglobulin (Dako) for 30 min. All incuba-
tions were carried out at 37°C in a humidified chamber and
were followed by extensive washes in PBS. Sections were
photographed as in Fig. 6. Alternatively, individual regions
of the brain were observed and antigen-positive cells were
counted in each region as in Fig. 7.
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